北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 核医学科  > 期刊论文
学科主题: 临床医学
题名:
miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2
作者: Fu, Jing1,2; Xu, Xiaojie2; Kang, Lei3; Zhou, Liying2; Wang, Shibin4; Lu, Juming1; Cheng, Long2; Fan, Zhongyi2; Yuan, Bin2; Tian, Peirong1; Zheng, Xiaofei5; Yu, Chengze4; Ye, Qinong2; Lv, Zhaohui1
关键词: miR-30a ; Eya2 ; Breast cancer ; Cell proliferation ; Cell migration
刊名: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
发表日期: 2014-03-07
DOI: 10.1016/j.bbrc.2014.01.174
卷: 445, 期:2, 页:314-319
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Biochemistry & Molecular Biology ; Biophysics
研究领域[WOS]: Biochemistry & Molecular Biology ; Biophysics
关键词[WOS]: EYES ABSENT ; COLORECTAL-CANCER ; EXPRESSION ; MICRORNA ; SPECIFICATION ; TRANSCRIPTION ; TRANSITION ; APOPTOSIS ; INVASION ; LINES
英文摘要:

Eye absent (Eya) proteins are involved in cell fate determination in a broad spectrum of cells and tissues. Aberrant expression of Eya2 has been documented in a variety of cancers and correlates with clinical outcome. However, whether microRNAs (miRNAs) can regulate Eya2 expression remains unknown. Here, we show that miR-30a represses Eya2 expression by binding to the 3′-untranslated region of Eya2. Overexpression of Eya2 in miR-30a-transfected breast cancer cells effectively rescued the inhibition of cell proliferation and migration caused by miR-30a. Knockdown of Eya2 by small-interfering RNA (siRNA) in breast cancer cells mimicked the effect induced by miR-30a and abolished the ability of miR-30a to regulate breast cancer cell proliferation and migration. The miR-30a/Eya2 axis could regulate G1/S cell cycle progression, accompanied by the modulation of expression of cell cycle-related proteins, including cyclin A, cyclin D1, cyclin E, and c-Myc. Moreover, miR-30a expression was downregulated in breast cancer patients, and negatively correlated with Eya2, which was upregulated in breast cancer patients. These data suggest that the miR-30a/Eya2 axis may play an important role in breast cancer development and progression and that miR-30a activation or Eya2 inhibition may be a useful strategy for cancer treatment. (C) 2014 Elsevier Inc. All rights reserved.

语种: 英语
所属项目编号: 2011CB504202 ; 2012CB945100 ; 81372161 ; 31100604 ; 81101065
项目资助者: Major State Basic Research Development Program ; National Natural Science Foundation
WOS记录号: WOS:000333228700009
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/55488
Appears in Collections:北京大学第一临床医学院_核医学科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Chinese Peoples Liberat Army Gen Hosp, Chinese PLA Med Sch, Dept Endocrinol, Beijing, Peoples R China
2.Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing 100850, Peoples R China
3.Peking Univ First Hosp, Dept Nucl Med, Beijing, Peoples R China
4.307 Hosp PLA, Dept Gen Surg, Beijing, Peoples R China
5.Beijing Inst Radiat Med, Beijing, Peoples R China

Recommended Citation:
Fu, Jing,Xu, Xiaojie,Kang, Lei,et al. miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,2014,445(2):314-319.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Fu, Jing]'s Articles
[Xu, Xiaojie]'s Articles
[Kang, Lei]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Fu, Jing]‘s Articles
[Xu, Xiaojie]‘s Articles
[Kang, Lei]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace